Mgi Pharma, Inc.
Records under this name other than patents Mgi Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,618,075 | Certain Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 8,951,987 | Certain Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 9,567,363 | Certain Compounds, Compositions and Methods Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,268,800 | Certain Compounds, Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 7,709,529 | Treatment of cancer with glutamine Formerly held Lapsed on the fee record Ended May 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2022 | From the USPTO record |
| US 7,601,800 | Compositions and Methods for Monitoring Breast Cancer Treatment Lapsed on the fee record Ended Oct 13, 2021 · High confidence | Lapsed on the fee record | Ended Oct 13, 2021 | High confidence |
| US 6,794,536 | Method for preparation of disodium pamidronate Formerly held Term ended Term ended Jan 11, 2021 · From the USPTO record | Term ended | Term ended Jan 11, 2021 | From the USPTO record |
| US 7,041,651 | Cellular uptake of bioactive agents Formerly held Term ended Term ended Aug 19, 2020 · From the USPTO record | Term ended | Term ended Aug 19, 2020 | From the USPTO record |
| US 6,268,524 | Method for preparation of disodium pamidronate Formerly held Term ended Term ended Aug 15, 2020 · From the USPTO record | Term ended | Term ended Aug 15, 2020 | From the USPTO record |
| US 6,734,170 | Cellular uptake of bioactive agents Formerly held Term ended Term ended Jul 21, 2020 · From the USPTO record | Term ended | Term ended Jul 21, 2020 | From the USPTO record |